[1]徐浩翔,王宝玺.反常性痤疮发病机制和治疗的研究进展[J]. 国际皮肤性病学杂志,2011,37(4):242-245.
[2]von Laffert M, Helmbold P, Wohlrab J, et al. Hidradenitis suppurativa(acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis [J]. Exp Dermatol, 2010,19(6):533-537.
[3]Mc Millan K. Hidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States.[J]. Am J Epidemiol, 2014,179(12):1477-1483.
[4]付思祺,范金财. 反常性痤疮的治疗进展[J]. 中华整形外科杂志,2013,29(1):73-77.
[5]仓 田, 王宝玺, 渠 涛. 反常性痤疮发病机制的研究进展[J]. 国际皮肤性病学杂志,2012,38(6):373-375.
[6]Van der Zee HH, Laman JD, Boer J, et al. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments [J]. Exp Dermatol, 2012, 21(10):735-739.
[7]仓 田,王宝玺,渠 涛,等.反常性痤疮的治疗进展[J]. 中华皮肤科杂志,2013,46(7):517-519.
[8]Danby FW, Hazen PG, Boer J. New and traditional surgical approaches to hidradenitis suppurativa [J]. J Am Acad Dermatol. 2015,73(5 Suppl 1):62-65.
[9]Wormald JC, Balzano A, Clibbon JJ, et al. Surgical treatment of severe hidradenitis suppurativa of the axilla: thoracodorsal artery perforator (TDAP) flap versus split skin graft[J]. J Plast Reconstr Aesthet Surg, 2014, 67(8):1118-24.
[10]李 侃,杜庆安,汪翠芸,等.负压封闭引流技术治疗大面积皮肤缺损伴感染[J]. 东南国防医药,2013,15(6):618-619.
[11]张颂楠,陈智勇,赵启明,等.反常性痤疮的中文期刊文献证据等级评价[J].中国医疗管理科学,2015,9(5):21-23.
[12]Alhusayen R, Shear NH. Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa[J]. J Am Acad Dermatol. 2015,73(5 Suppl 1):42-46.